Proclara Biosciences' Series B - II Round

Proclara Biosciences raised a round of funding on March 08, 2012.

Proclara Biosciences, formerly NeuroPhage Pharmaceuticals, is a biotechnology company advancing product candidates developed based on proprietary GAIM technology, which is capable of simultaneously ta…

Articles about Proclara Biosciences' Series B - II Round: